Reversal of experimental allergic encephalomyelitis with non-mitogenic, non-depleting anti-CD3 mAb therapy with a preferential effect on T(h)1 cells that is augmented by IL-4.

Source:http://linkedlifedata.com/resource/pubmed/id/11526091

Download in:

View as

General Info

PMID
11526091